It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESLOY’s FA Score shows that 2 FA rating(s) are green whileOLYMY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESLOY’s TA Score shows that 3 TA indicator(s) are bullish while OLYMY’s TA Score has 5 bullish TA indicator(s).
ESLOY (@Pharmaceuticals: Other) experienced а -0.05% price change this week, while OLYMY (@Medical/Nursing Services) price change was +9.96% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.
ESLOY is expected to report earnings on Oct 16, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.02% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ESLOY | OLYMY | ESLOY / OLYMY | |
Capitalization | 140B | 14.2B | 986% |
EBITDA | 6.71B | 180B | 4% |
Gain YTD | 30.529 | -14.651 | -208% |
P/E Ratio | 50.77 | 18.29 | 278% |
Revenue | 27.2B | 979B | 3% |
Total Cash | 3.16B | 275B | 1% |
Total Debt | 14B | 245B | 6% |
ESLOY | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 15 | |
SMR RATING 1..100 | 96 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 28 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ESLOY | OLYMY | |
---|---|---|
RSI ODDS (%) | 4 days ago56% | N/A |
Stochastic ODDS (%) | 4 days ago61% | 4 days ago74% |
Momentum ODDS (%) | 4 days ago43% | 4 days ago58% |
MACD ODDS (%) | 4 days ago51% | 4 days ago63% |
TrendWeek ODDS (%) | 4 days ago49% | 4 days ago61% |
TrendMonth ODDS (%) | 4 days ago53% | 4 days ago59% |
Advances ODDS (%) | 4 days ago60% | 6 days ago63% |
Declines ODDS (%) | 7 days ago50% | 11 days ago65% |
BollingerBands ODDS (%) | 4 days ago40% | 4 days ago69% |
Aroon ODDS (%) | 4 days ago46% | 4 days ago65% |
A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.
Ticker / NAME | Correlation To ESLOY | 1D Price Change % | ||
---|---|---|---|---|
ESLOY | 100% | +0.13% | ||
ESLOF - ESLOY | 58% Loosely correlated | -2.34% | ||
SMMNY - ESLOY | 41% Loosely correlated | +0.80% | ||
SAUHY - ESLOY | 37% Loosely correlated | +0.51% | ||
CLPBY - ESLOY | 33% Poorly correlated | +2.59% | ||
LZAGY - ESLOY | 32% Poorly correlated | +0.64% | ||
More |
A.I.dvisor indicates that over the last year, OLYMY has been loosely correlated with OCPNF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if OLYMY jumps, then OCPNF could also see price increases.
Ticker / NAME | Correlation To OLYMY | 1D Price Change % | ||
---|---|---|---|---|
OLYMY | 100% | +4.87% | ||
OCPNF - OLYMY | 52% Loosely correlated | N/A | ||
TRUMY - OLYMY | 44% Loosely correlated | +0.56% | ||
SSMXY - OLYMY | 33% Loosely correlated | +2.26% | ||
HOCPY - OLYMY | 32% Poorly correlated | +3.59% | ||
ESLOY - OLYMY | 23% Poorly correlated | +0.13% | ||
More |